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Crystal structure of the conserved core
of the herpes simplex virus
transcriptional regulatory protein VP16
Yu Liu,1,4 Weimin Gong,1,2,5 C. Chris Huang,1,3,6 Winship Herr,1 and Xiaodong Cheng1,2,7
1Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724 USA; 2Department of Biochemistry, Emory
University School of Medicine, Atlanta, Georgia 30322 USA; 3Graduate Program in Genetics, State University of New York
at Stony Brook, Stony Brook, New York 11794 USA
On infection, the herpes simplex virus (HSV) virion protein VP16 (Vmw65; aTIF) forms a transcriptional
regulatory complex—the VP16-induced complex—with two cellular proteins, HCF and Oct-1, on
VP16-responsive cis-regulatory elements in HSV immediate-early promoters called TAATGARAT.
Comparison of different HSV VP16 sequences reveals a conserved core region that is sufficient for
VP16-induced complex formation. The crystal structure of the VP16 core has been determined at 2.1 Å
resolution. The results reveal a novel, seat-like protein structure. Together with the activity of mutant VP16
proteins, the structure of free VP16 suggests that it contains (1) a disordered carboxy-terminal region that
associates with HCF, Oct-1, and DNA in the VP16-induced complex, and (2) a structured region involved in
virion assembly and possessing a novel DNA-binding surface that differentiates among TAATGARAT
VP16-response elements.
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Herpes simplex virus (HSV) is a large double-stranded
DNA virus, which is transcribed and replicated in the
host cell nucleus. During infection, the viral genes are
coordinately expressed in three phases—immediate early
(IE) or a, delayed-early or b, and late or g. This cascade of
viral gene expression is initiated by an HSV virion pro-
tein called VP16 (also called aTIF, Vmw65, or VF65) (for
reviews, see Thompson and McKnight 1992; O’Hare 1993).
VP16 has multiple roles during the HSV infection
cycle. It is synthesized late during infection and is incor-
porated into the tegument of the virion with other viral
proteins, including the regulatory virion host shutoff
protein vhs (Smibert et al. 1994). On de novo infection,
VP16 is released into the cell and associates with two
cellular factors, HCF (also called C1, CFF, and VCAF)
and Oct-1, on HSV IE promoters at VP16-responsive sites
called TAATGARAT. VP16 first binds HCF, a nuclear
factor involved in cell proliferation (Goto et al. 1997),
and subsequently VP16 and HCF together associate with
Oct-1, a POU domain transcription factor, on the TAAT-
GARAT (R = purine) element. Once targeted to HSV IE
promoters through association with HCF and Oct-1,
VP16 activates IE-gene transcription through a potent
carboxy-terminal transcriptional activation domain.
Therefore, VP16 is a multifaceted protein that, at differ-
ent times during the HSV infection cycle, interacts with
either viral proteins, as in the virion, or cellular proteins,
as in the VP16-induced complex.
The structure and assembly of the VP16-induced com-
plex has been studied extensively. VP16 likely contacts
each of the other components of the VP16-induced com-
plex—HCF, Oct-1, and DNA. In HCF, a large protein of
>2000 amino acids (Wilson et al. 1993; Kristie et al.
1995), VP16 binds to a stable 380-amino-acid amino-ter-
minal domain (LaBoissie`re et al. 1997; Wilson et al.
1997). In Oct-1, VP16 interacts with its DNA-binding
POU domain (Kristie et al. 1989; Stern et al. 1989). The
POU domain is a bipartite DNA-binding domain consist-
ing of two helix–turn–helix DNA-binding structures, a
POU-specific (POUS) domain and a POU-homeo (POUH)
domain, which are connected by a flexible linker (for
review, see Herr and Cleary 1995). VP16 discriminates
among the POUH domains of different POU proteins
(Stern and Herr 1991; Lai et al. 1992; Pomerantz et al.
1992) and among different TAATGARAT elements pres-
ent in different HSV genomes (Huang and Herr 1996;
Misra et al. 1996).
VP16 is a modular protein of 490 amino acids. The
potent transcriptional activation domain is located
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within the carboxy-terminal 80 amino acids (Sadowski
et al. 1988; Triezenberg et al. 1988; Cousens et al. 1989),
whereas sequences sufficient for VP16-induced complex
assembly encompass much of the remainder of the pro-
tein (Greaves and O’Hare 1990). Comparison of the HSV
VP16 sequence with those of the related proteins from
other herpesviruses reveals that the region sufficient for
VP16-induced complex assembly is conserved, whereas
the sequence of the transcriptional activation domain is
not conserved. Here, we describe the X-ray crystal struc-
ture of the free form of the conserved VP16-induced com-
plex forming region. The results reveal a novel, seat-like
protein structure. Sequences involved in DNA-sequence
recognition and productive virion assembly are struc-
tured, but sequences involved in associating with HCF
and Oct-1 are disordered, suggesting that VP16 under-
goes conformational changes during VP16-induced com-
plex assembly.
Results and Discussion
A conserved VP16 core
The sequence of VP16 homologs has been determined
from a number of different herpesviruses (Fig. 1). The
length of these VP16 proteins varies from 410 amino
acids in varicella zoster virus (VZV) to 504 amino acids
in bovine herpesvirus type 1 (BHV-1), but they all con-
tain a conserved core region of ~ 350 amino acids (Fig.
1A). We refer to this conserved region of VP16 as the
VP16 core. The position of the conserved VP16 core var-
ies from a central location in the HSV type 1 (HSV-1),
equine herpesvirus type 1 (EHV-1), and BHV-1 VP16 pro-
teins to a carboxy-terminal location in the VZV and gal-
lus herpesvirus type 1 (GHV-1) VP16 proteins. In HSV-1
VP16, the amino-terminal 48 amino acids and the car-
boxy-terminal 78 amino acids—the transcriptional acti-
vation domain—are not highly conserved. In the studies
described here, we focused our structural analysis of
VP16 on the VP16 core because (1) deletion analysis of
VP16 has shown that this region of VP16 is sufficient for
VP16-induced complex assembly (Greaves and O’Hare
1990) and (2) structural studies of the VP16 transcrip-
tional activation domain have indicated that, on its own,
its structure is unstable (Donaldson and Capone 1992;
O’Hare and Williams 1992; Shen et al. 1996; Uesugi et al.
1997).
Figure 2 shows a sequence alignment of HSV-1 VP16
residues 49–412 and the corresponding residues of the
VZV, GHV-1, EHV-1, and BHV-1 VP16 proteins. The se-
quence alignment reveals sequence conservation through-
out the entire region, with invariant or conservatively
substituted positions scattered throughout the conserved
core. Only three regions of the conserved core have suf-
fered insertions or deletions in the different homologs
(around HSV-1 VP16 residues 125, 200, and 347–382) and
the size of insertion or deletion is never more than five
residues. This sequence comparison suggests that the
functions of the conserved VP16 core require extensive
sequence conservation and therefore structural conser-
vation.
To prepare the VP16 core for crystallography, we syn-
thesized the HSV-1 VP16 core (residues 49–412) fused at
its amino-terminus to glutathione S-transferase (GST–
VP16) in Escherichia coli and separated the VP16 se-
quences from the GST moiety by proteolytic digestion.
As shown in Figure 1B, VP16 residues 1–412 fused to
GST (GST–VP16DC) are active for VP16-induced com-
plex (labeled VIC) assembly in an electrophoretic mobil-
ity retardation assay before and after proteolytic diges-
Figure 1. Conserved VP16-core region. (A)
Schematic representation of VP16 ho-
mologs from five herpesviruses and delin-
eation of the VP16-core protein used for
crystallography. The VP16 homologs are
derived from HSV-1 (strain 17; Campbell et
al. 1984; Dalrymple et al. 1985), VZV (Davi-
son and Scott 1986), GHV-1 (Yanagida et al.
1993), EHV-1 (Telford et al. 1992), and
BHV-1 (Carpenter and Misra 1992). A con-
served VP16-core region is shown in dark
gray and the carboxy-terminal HSV-1 tran-
scriptional activation domain (AD) is
shown in light gray. The HSV-1 VP16 core
(49–412) protein is shown at the bottom
with the structured regions identified by
x-ray diffraction shown in black. (B) Elec-
trophoretic mobility retardation assay of
GST–VP16 fusion proteins synthesized in
E. coli. A labeled (OCTA+)TAATGARAT
site from the HSV-1 ICP0 promoter (Stern
et al. 1989) was used for electrophoretic mobility retardation as described (Huang and Herr 1996). (Lane 1) Free probe; (lanes 2–6),
partially purified HeLa-cell Oct-1 and HCF (the wheat germ agglutinin fraction; Wilson et al. 1993); (lane 3) GST–VP16DC; (lane 4)
VP16DC; (lane 5) GST–VP1649–412 core; (lane 6) VP1649–412 core. The positions of the free probe, Oct-1–DNA (Oct-1) complex, and
VP16-induced complex (VIC) are indicated on the left.
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tion (Fig. 1B, cf. lanes 3 and 4). Consistent with previous
studies in eukaryotic cells (Greaves and O’Hare 1990),
further deletion of VP16 amino-terminal residues 1–48
(labeled Core in Fig. 1B) had no adverse effect on VP16-
induced complex formation either as a GST fusion pro-
tein (Fig. 1B, lane 5) or as a free protein after proteolysis
(Fig. 1B, lane 6). Deletion of the amino-terminal residues,
however, offered an important benefit for the crystallog-
raphy studies described here because synthesis of this
protein in E. coli is more efficient than that of the longer
VP16 protein. We therefore chose to determine the struc-
ture of HSV-1 VP16 residues 49–412.
Structure determination
We calculated electron density maps by isomorphous re-
placement of mercuric derivatives (Table 1) and were
able to build a total of 309 of the 364 residues of the
Figure 2. Sequence alignment of the con-
served VP16-core region from HSV-1,
VZV, GHV-1, EHV-1, and BHV-1 and
alignment with structural elements of the
VP16-core protein. The HSV-1 residue
numbering is shown above the sequence
alignment. Amino acids highlighted are ei-
ther invariant (white against black) among
the five proteins or similar (shaded) as de-
fined by the following groupings: V, L, I,
and M; F, Y, and W; K and R; E and D; Q
and N; S and T; and A, G, and P. The color
coding is as described in the text; a helices
are labeled A–K (helix aG is subdivided
into helices aG8 and aG88 owing to a dis-
continuity in this helix); b strands are la-
beled 1–6; turns and loops (L) are referred
to by their flanking secondary structures;
broken lines indicate disordered regions.
Polar interactions among conserved resi-
dues that are seen to exert their effect on
the structure of VP16 as a whole include
ion pairings (R64–D68, D97–R162, E160–
H131, R164–E237, E165–K343, R214–
E218, and R308–E313), polar side-chain– side-chain interactions (D87–S90, Y149–Q246, Y99–E165, S106–D111, Y168–H229, Y231–
K343), polar side-chain–main-chain interactions (N85–H326, N85–A330, S106–L108, S186–Y182, Y215–F104, Y216–S106, R237–L302,
R264–S90, N296–V307, R299–P305, R299–L269), and water-mediated polar interactions (S106-H2O–S348, E160-H2O–E237, Y182-
H2O–R214, Y335-H2O–A330).
Table 1. X-ray data collection and phasing statistics at 3.0 Å resolution
Native HgCl2 pCMBS
Crystal nos. 1 and 2 no. 3 no. 3 no. 4 no. 5 no. 6 no. 6
Cell dimensions (Å) a = 59.5 b = 77.1 c = 84.0
Wavelength (Å) 1.5418 1.01299 1.015562
Energy (KeV) 8.042 12.241 12.210
I cutoff I/s(I) 2 2 2 2 2 0 0
Resolution limit (Å) 3 3 3.5 3 3 2.6 2.6
Completeness (%)a 94/86 72/71 75/76 70/38 84/65 96/94 95/91
R linear (%)a 8.8/20.7 10.5/31.9 12.9/22.9 10.8/22.3 11.9/21.2 6.1/15.9 6.1/16.3
<I/s(I)>a 11/5 8/3 7/3 8/3 9/3 13/6 11/5
Observed reflections (no.) 50575 15183 10594 13886 20095 37731 37130
Unique reflections (no.) 7498/335 5796/277 3953/192 5746/143 6800/255 11579/543 11751/560
Anomalous pairs (no.) — — — — — 9263 8899
Mercury sites (no.) — 4 4 4 4 5 5
Isomorphous/anomalous — iso iso iso iso ano ano
Phasing power — 1.95 1.75 1.27 1.47 1.28 0.95
RCullis — 0.537 0.505 0.633 0.533 — —
RKraut — 0.130 0.133 0.113 0.146 0.404 0.420
Figure of merit — 0.374 0.363 0.301 0.326 0.277 0.234
Overall figure of merit 0.567
aNumerical numbers are given for the whole data set/highest resolution bin.
Liu et al.
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HSV-1 VP16 core protein into a model: residues 49–349
and 395–402. Residues 350–394 (45 residues) and 403–
412 (10 residues) are missing and apparently disordered
in the crystal (see Fig. 1A, bottom). The model was re-
fined to 2.1 Å resolution with a crystallographic R factor
of 0.19 and Rfree value of 0.26 (Table 2).
Overall structure
Figure 3 presents two views of the determined VP16-core
structure; the location of structural elements with re-
spect to the amino-acid sequence of HSV-1 VP16 is
shown in Figure 2. In Figures 2 and 3, the regions of the
molecule have been colored, from amino to carboxyl ter-
minus, red (residues 49–145), green (residues 146–247),
blue (residues 248–323), and yellow (residues 324–412).
In the orientation shown in Figure 3A, the missing
amino-terminal segment (residues 1–48) would enter the
determined structure from the left side (labeled 49) and
the missing carboxy-terminal 78-residue transcriptional
activation domain would leave the molecule at the bot-
tom. In the same view, the major disordered region of the
determined structure (residues 350–394) lies to the right
of the molecule and is indicated by a broken line.
The overall structure of the VP16 core, as viewed in
Figure 3B, resembles a seat with the back of the seat at
the right. We use this seat analogy to describe the mol-
ecule and refer to the view shown in Figure 3A as the
front view and the view shown in Figure 3B as the right-
side view (the point of view of an observer from the right
side of Fig. 3A). To describe the structure, we divide it
into three parts: the back (green), bottom (blue), and the
top surface (red and yellow) of the seat. With respect to
the primary sequence, the seat back and bottom each
consist of contiguous sequences, whereas the surface of
the seat is composed of elements from the amino-termi-
nal region (helix aB in red) and the carboxy-terminal re-
gion (helix aK in yellow).
Structured segments
Viewed from the front (Fig. 3A), the structured regions of
VP16 display considerable internal structural symmetry.
There are two principal elements to this symmetry. The
first element is the seat surface, consisting of helices aB
(red) and aK (yellow), which form a V-like structure that
links the amino- and carboxy-terminal regions of VP16
together. The second element represents the most domi-
nating feature of the VP16 structure: a two-stranded an-
tiparallel coiled–coil formed by two long a helices—he-
lix aF of 51 amino acids and helix aG of 45 amino ac-
ids—which form the seat back (colored green; note that
in Fig. 2 helix aG is labeled G8/G88 owing to a kink in
this helix that is described below). These two long heli-
ces are connected by a short six-amino-acid loop (L-FG)
at the top of the seat back, forming the center of what we
refer to as a headrest (see Fig. 2). The two pairs of sym-
metrical helices—aB and aK on the seat surface, and aF
and aG at the seat back—lie nearly perpendicular to one
Table 2. Structural refinement statistics at 2.1 Å resolution
Crystal no. 7
Cell dimensions (Å) 59.5 × 75.2 × 81.1
Temperature (K) 95
Wavelength 1.1000





Observed reflections (no.) 143578/−
Unique reflections (no.) 21163/1008
Protein atoms (no.) 2460 (the side chain
of V225 was modeled
in a dual conformation)
Water molecules (no.) 178
Phosphate ions (no.) 2
Root-mean-square deviation from ideality
bond lengths (Å) 0.01
bond angles (°) 1.5
dihedrals (°) 21.8
improper (°) 1.4
Average thermal factor (Å2)
main chain 20.0 ± 1.7
side chain 22.3 ± 3.3
water 28.7
Ramachandran plot






Reflections (no.) R value/Rfree
7.00–2.10 92.9/19677 0.192/0.260
2.19–2.10 86.5/2262 0.255/0.320
Figure 3. Ribbon (Carson 1991) diagrams of the VP16-core pro-
tein, colored red (residues 49–145), green (146–247), light blue
(248–323), and yellow (324–412). (A) Front view; (B) right-side
view.
VP16 structure
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another and are largely responsible for the seat-like ap-
pearance of VP16.
Two other overall structural elements of the VP16
structure are the amino-terminal region shown in red
and the seat bottom shown in blue (Fig. 3). The amino-
terminal region (red) is critical to the structural integrity
of the molecule; it wraps around the middle of the mol-
ecule. Helix aE is positioned approximately perpendicu-
lar to the axis of the coiled–coil structure forming a sup-
port for the headrest, followed by the most pronounced
loop of the VP16-core structure: the 27-amino-acid-long
L-EF loop (residues 119–145); this loop extends along
nearly the entire length of the back of the molecule (see
Fig. 3B) and connects to helix aF of the coiled–coil struc-
ture.
The seat bottom contains all of the strands (b1–b6)
present in the VP16 core. The strand b6 shown in yellow
is near the carboxyl terminus of the VP16-core protein.
The strands form two b sheets: a two-stranded parallel b
sheet (strands b5 and b2) and a four-stranded mixed an-
tiparallel b sheet (strands b4, b3, b1, and b6). Strands b2
and b3 are connected by a sharp turn at the invariant
glycine G278 (see Fig. 2), causing a nearly perpendicular
orientation of the two b sheets (see Fig. 3B).
Segment involved in HCF/Oct-1/DNA interactions
is disordered
The dashed yellow lines in Figures 2 and 3 identify the
two segments of the crystallized VP16-core protein that
are not represented in the determined structure: residues
350–394 and carboxy-terminal residues 403–412. The
disorder of the carboxy-terminal residues (403–412) may
indicate the beginning of a disordered transcriptional ac-
tivation domain (Donaldson and Capone 1992; O’Hare
and Williams 1992; Shen et al. 1996). The other, larger
disordered segment (residues 350–394) is critical for
VP16-induced complex assembly. Numerous insertion,
deletion, and point mutation analyses (Ace et al. 1988;
Werstuck and Capone 1989; Greaves and O’Hare 1990;
Stern and Herr 1991; Walker et al. 1994; Shaw et al. 1995;
Lai and Herr 1997), and peptide studies (Haigh et al.
1990; Stern and Herr 1991; Hayes and O’Hare 1993; Wu
et al. 1994; Simmen et al. 1997) have identified this seg-
ment as important for VP16-induced complex formation
and interaction with HCF, Oct-1, and DNA. The activity
of individual point mutations in VP16 and synthetic pep-
tides has shown that residues E361, H362, and Y364 are
involved in contacting HCF (Freiman and Herr 1997; Lai
and Herr 1997; Simmen et al. 1997; Lu et al. 1998); resi-
dues Y373, G374, and S375 are involved in recognizing
Oct-1 (Walker et al. 1994; Lai and Herr 1997); and resi-
dues R360, R366, R368, and K370 are involved in binding
DNA (Shaw et al. 1995; Lai and Herr 1997). We hypoth-
esize that this HCF/Oct-1/DNA-interaction segment of
VP16 is unstructured in its native state, but adopts struc-
ture on binding to HCF, Oct-1, and DNA in the VP16-
induced complex. Consistent with this hypothesis, VP16
residues 365–370 are susceptible to proteolytic digestion
in the free VP16 molecule but are protected from diges-
tion in the VP16-induced complex, suggesting that these
residues represent a major surface-exposed site that is
covered in the VP16-induced complex (Hayes and
O’Hare 1993).
There is an excellent precedent for the hypothesis that
a disordered segment of VP16 adopts a stable structure
on formation of VP16-induced complex. Structural stud-
ies have shown that a disordered segment of the yeast
transcriptional regulator MATa2 adopts a stable a heli-
cal structure on complex formation with the homeodo-
main of the MATa2-coregulator MATa1 (Li et al. 1995).
Mutational analyses of the Oct-1 POUH domain (Pomer-
antz et al. 1992) and VP16 (Stern and Herr 1991; Walker
et al. 1994; Lai and Herr 1997), and sequence similarity
between VP16 (372-NYGSTIEGLL-381) and MATa2 (59-
TIAPELADLL-68) suggested that VP16 contacts the
Oct-1 POUH domain in the same manner as MATa2
contacts the MATa1 homeodomain (Li et al. 1995). Our
finding that, as in MATa2, the homeodomain interac-
tion region of free VP16 is disordered is consistent with
this hypothesis and suggests that this region of VP16
undergoes a conformational change on binding to Oct-1.
These results extend the remarkable similarity between
a yeast transcriptional coregulator interaction and a hu-
man viral and cellular coregulator interaction.
Between the disordered HCF/Oct-1/DNA-interaction
segment of VP16 and the disordered carboxy-terminal
segment leading to the transcriptional activation domain
is a short structured segment of eight amino acids that
contains strand b6 (yellow) and forms part of the seat
bottom (Fig. 3). This segment is of considerable interest
because it tethers the HCF/Oct-1/DNA-interaction re-
gion to the body of VP16 and positions the transcrip-
tional activation domain at the bottom of the structure
(see Fig. 3). Furthermore, the position of strand b6 as the
outermost strand of the four-stranded sheet of the seat
bottom suggests that it could be detached from the body
of VP16 without disrupting the structured region of the
free VP16 core. Perhaps, during VP16-induced complex
assembly or transcriptional activation, strand b6 be-
comes detached from the remainder of VP16 providing a
mechanism for conformational changes in VP16 during
regulation of transcription.
Virion assembly surface
Ace et al. (1988) described the first mutational analysis
of VP16 and the results of this study are easily inter-
preted with respect to the VP16-core structure presented
here. In that study, four-amino-acid insertions were
made throughout the VP16 molecule and the corre-
sponding mutants were assayed for virion assembly,
VP16-induced complex formation, and transcriptional
activation. Seven of these insertions were within the
VP16-core region crystallized here, between residues
G74/P75, G145/L146, L172/A173, S177/A178, R249/
P250, E288/A289, and G379/L380. The position of five
of the seven mutants is shown in the rear and left-side
views of VP16 shown in Figure 4; one of the seven mu-
tants, G379/L380, lies within the disordered region, and
Liu et al.
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another, S177/A178, is buried in the VP16 structure and
is therefore not visible in the molecular surface repre-
sentation shown in Figure 4.
The seven insertion mutants fall into four different
classes: (1) wild-type activity (G145/L146); (2) active for
virion assembly but not VP16-induced complex forma-
tion (G379/L380); (3) active for VP16-induced complex
formation or transactivation but not virion assembly
(G74/P75, R249/P250, and E288/A289); and (4) inactive
for both VP16-induced complex formation and virion as-
sembly (L172/A173 and S177/A178) (Ace et al. 1988).
Consistent with these results, the inactive mutants
L172/A173 and S177/A178 map within the center of the
protein in the coiled–coil helix aF (see Fig. 4A)—these
mutations probably disrupt the overall structure of
VP16—whereas the mutant with wild-type activity,
G145/L146, lies on the surface of VP16 (at the end of
loop L-EF). The mutation that is active for virion assem-
bly but not VP16-induced complex formation, G379/
L380, lies within the disordered HCF/Oct-1/DNA-inter-
action segment, and is now known to affect interaction
with Oct-1 (Stern and Herr 1991). Interestingly, the three
mutations that are active for VP16-induced complex for-
mation or transactivation but not virion assembly all
map on the side of the molecule opposite to the HCF/
Oct-1/DNA-interaction segment (Fig. 4B). Therefore,
the activities of these VP16 insertion mutants suggest
that different surfaces of VP16 are used for different func-
tions—the right side (Fig. 3B) of VP16 is intimately in-
volved in the control of gene expression by promoting
VP16-induced complex assembly and activation of HSV
immediate-early gene expression, and the left side (Fig.
4B, below) is intimately involved in virion assembly.
Perhaps, the virion-assembly surface is involved in asso-
ciation with the virion tegument protein vhs (Smibert et
al. 1994).
Conserved residues
As noted above, highly conserved residues of VP16 are
scattered throughout the conserved core region (see Fig.
2). The structure of the VP16 core offers a rationale for
their conservation: The large majority of the conserved
amino acids is involved in structural packing and intra-
molecular interactions. For example, conserved hydro-
phobic side chains intercalate with each other at the in-
terfaces of the a helices to form the hydrophobic core of
the molecule. Unexpectedly, however, many of the in-
variant and conserved residues are polar or charged, and
are involved in intramolecular interactions that likely
confer stability to the molecule (see legend to Fig. 2).
Figure 5 illustrates three of these interactions in detail.
Figure 5A shows a network of polar interactions involv-
ing the invariant residue K343. In a previous study, sub-
stitution of K343 for alanine resulted in complete inac-
tivation of VP16 and poor VP16 synthesis in E. coli sug-
gesting a major disruption of the VP16 structure (Lai and
Herr 1997). Consistent with this hypothesis, K343 is bur-
ied in the center of the structure and is critical for sta-
bilizing a network of polar interactions involving the
Figure 4. Position of insertion mutations (green) prepared by
Ace et al. (1988) on a molecular surface representation of VP16
(Nicholls et al. 1991). (A) Rear view; (B) Left-side view.
Figure 5. Views of defined elements in
the VP16 structure. (A) Network of inter-
nal charged interactions centered on resi-
due K343. (B) Loop L-BC (red) between he-
lix aK (yellow) and the seat bottom (blue).
(C) Solvent-exposed and invariant ar-
ginines 214 and 217 and the discontinuity
point of helix aG. [Produced by MOL-
SCRIPT (Kraulis 1991)].
VP16 structure
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amino-terminal (red), coiled–coil (green), and carboxy-
terminal (yellow) segments of the VP16 core. This net-
work of interactions involves (1) a main-chain carbonyl
group of the amino-terminal residue P93 interacting
with Y231 of helix aG of the coiled–coil; (2) Y231 inter-
action with K343 of carboxy-terminal helix aK; (3) K343
interaction with E165 of helix aF also of the coiled–coil;
(4) E165 interaction with amino-terminal residues Y99
and N95; (5) N95 interaction with R162 of helix aF; and
(6) R162 interaction with amino-terminal residue D97.
Emphasizing the importance of these interactions is
the observation that residues P93, Y99, E165, Y231, and
K343 are invariant in the five VP16 homologs shown in
Figure 2. Furthermore, in the case of the three other resi-
dues, N95 varies in only one of the VP16 homologs—this
position is a histidine in EHV-1, a conservative change—
and residues D97 and R162 also only differ in GHV-1 and
here there is covariation: in GHV-1 residues correspond-
ing to D97 and R162 are histidine and glutamic acid,
respectively. Therefore, at the center of the VP16 core
lies an extensive network of stabilizing polar interac-
tions.
Figure 5B shows a highly conserved stretch of six
amino acids, of which three are charged or polar (residues
85–90; see Fig. 2), located in the amino-terminal region
of the VP16 core. These residues pass through the mol-
ecule between the carboxy-terminal helix aK (yellow)
and the seat bottom (blue), performing an apparently
critical function of stabilizing the association of the seat
bottom with the surface of the seat. The invariant resi-
due N85 is stabilized by a network of water molecules as
well as interactions with the main chain. The following
residue, E86, forms hydrogen bonds with two residues in
the seat bottom, W263 in loop L-1I and R291 in helix aJ.
Although the set of three residues in the R291–E86–
W263 interaction (R–E–W) is not present in any of the
other VP16 homologs, there is covariation that suggests
a conserved interaction: The corresponding positions in
VZV are A–E–R, in EHV-1, D–E–R, and in BHV-1, E–E–R.
Therefore, in these proteins an arginine is present at the
position corresponding to 263 rather than 291, probably
still maintaining the ion-pair interaction with the E86
position. GHV-1 (with residues E–V–E) is the exception
in which neither E86 nor an arginine are conserved;
these residues may form an alternate interaction.
Although most of the conserved residues in VP16 are
involved in intramolecular interactions, the most highly
conserved segment—the five consecutive invariant resi-
dues RYYRE (residues 214–218)—involves residues that
are exposed on the surface of the molecule (Fig. 5C). The
tyrosine doublet Y215 and Y216 is buried, making main-
chain contacts with residues F104 and S106, respec-
tively. R217, however, is solvent exposed and R214 and
E218 form an ion pair on the solvent-exposed surface of
the helix. Just above the RYYRE segment, there is a dis-
continuity in helix aG where a water molecule is situ-
ated in the kink by hydrogen bonding to the main-chain
oxygen atoms of A212 and D213 and to the main-chain
nitrogen atoms of Y216 and R217 (Fig. 5C). As described
below, we hypothesize that the conserved arginines 214
and 217 are involved in DNA binding; perhaps, the dis-
continuity in helix aG can be altered to cause a confor-
mational change in the headrest upon interaction with
DNA or some other molecule.
DNA-binding specificity determinants of VP16
VP16 can bind DNA on its own (Kristie and Sharp 1990;
Stern and Herr 1991) and homologs of VP16 from differ-
ent herpesviruses can display different DNA-binding
specificities. For example, HSV-1 and BHV-1 VP16 pro-
teins recognize different TAATGARAT VP16-response
elements (Huang and Herr 1996; Misra et al. 1996). The
DNA sequences responsible for this difference in DNA-
binding specificity are a 3-bp determinant (D) element
that lies 38 of the core TAATGARAT consensus se-
quence TAATGAG/AAT. HSV-1 VP16 recognizes the
D-element sequence CTT, but not GGC, in the TAAT-
GARAT-element sequence ATGCTAATGAGATTCTT
(the D element is underlined), whereas BHV-1 VP16 rec-
ognizes the D-element sequence GGC, but not CTT
(Huang and Herr 1996). The region of VP16 responsible
for D-element recognition is not known. Because, in ad-
dition to associating with HCF and Oct-1, the disordered
region of the HSV-1 VP16 core interacts with DNA
(Shaw et al. 1995; Lai and Herr 1997), we asked whether
substituting the corresponding region of BHV-1 VP16
with the disordered region of HSV-1 VP16 would alter
the DNA-binding specificity of BHV-1 VP16 (Fig. 6).
We created a BHV-1/HSV-1 VP16 (B/H-VP16) recom-
binant carrying BHV-1 VP16 (B-VP16) sequences cover-
ing the amino-terminal structured region of VP16 and
HSV-1 VP16 (H-VP16) sequences representing the car-
boxy-terminal disordered region of VP16 (see Fig. 6B).
As shown in Figure 6A, we compared the ability of
H-VP16, B-VP16, and the recombinant B/H-VP16 pro-
teins to form VP16-induced complexes in an electropho-
retic mobility retardation assay on two related TAAT-
GARAT elements. One element, called H-TAAT, con-
tains the HSV-1 VP16-responsive D-element sequence
CTT, whereas the other element, called B-TAAT, con-
tains the BHV-1 VP16-responsive D-element sequence
GGC. Consistent with previous results (Huang and Herr
1996), H-VP16 recognized the H-TAAT element (Fig. 6A,
lane 3), but not the B-TAAT element (Fig. 6A, lane 4),
whereas B-VP16 recognized the B-TAAT element (Fig.
6A, lane 8) but not the H-TAAT element (Fig 6A, lane 7).
To our surprise, the B/H-VP16 recombinant displayed
the same DNA-recognition properties as B-VP16: It rec-
ognized the B-TAAT element (Fig. 6A, lane 6) but not the
H-TAAT element (Fig. 6A, lane 5). These results indicate
that the disordered HCF/Oct-1/DNA-interaction region
of native VP16 is not responsible for the difference in
DNA-sequence recognition by the HSV-1 and BHV-1
VP16 proteins, and suggest instead that the structured
region of the conserved VP16 core is responsible for
D-element recognition.
An alternative hypothesis is that the nonconserved
amino-terminal region of VP16 (residues 1–48 in HSV-1
VP16), which was retained in the constructs assayed in
Liu et al.
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this experiment, is responsible for this difference in
VP16 DNA-binding specificity. We do not favor this hy-
pothesis because this nonconserved region is not re-
quired for DNA binding (see Fig. 1B) or D-element rec-
ognition (R. Babb and W. Herr, unpubl.) by VP16. We
therefore examined the VP16-core structure for a pos-
sible DNA-binding surface.
A potential structured VP16 DNA-binding surface
To identify a DNA-binding surface on VP16, we dis-
played a molecular surface representation of the VP16
core showing the surface charge distribution. Figure 7
shows three views of such a representation of the VP16
core. Acidic (red) and basic (blue) surfaces are not evenly
distributed over VP16. For example, there are regions on
the right side of the VP16 core that are enriched in acidic
residues (Fig. 7C). In contrast, in the left-side view
shown in Figure 7A, two prominent basic surfaces can be
seen: the convex surface on the back of the headrest con-
sisting of residues R181, R184, R188, and R192, and the
concave surface of the seat consisting of residues R214,
R217, R221, R224, R331, and R341. The basic region on
the concave surface can also be seen in the front view
shown in Figure 7B. We suggest that the basic concave
surface represents a DNA-binding surface because (1)
substitution of arginines 331 and 341 with alanine im-
pairs VP16-induced complex formation by disrupting the
ability of VP16 to bind DNA (Lai and Herr 1997), and (2)
the solvent exposed residues R214 and R217 (see Fig. 5C)
are invariant among the VP16 homologs shown in Figure
2, suggesting that they are involved in a conserved func-
tion such as DNA contacts. In contrast, the arginines on
the back of the convex headrest are not highly conserved
among VP16 homologs (see Fig. 2).
A hypothetical model of a VP16/Oct-1 DNA complex
Encouraged by the identification of a potential DNA-
binding surface on VP16, we attempted to create a model
of VP16 bound to a TAATGARAT element with the
Oct-1 POU domain. To prepare the model, we used the
coordinates for the cocrystal structure of the Oct-1 POU
domain bound to an octamer element (Klemm et al.
1994) and extended the DNA with B-helical DNA to in-
clude the D element of a complete TAATGARAT ele-
ment. We then positioned the putative concave DNA-
binding surface of VP16 over the 3-bp D element, in an
orientation such that the unstructured region of VP16
that interacts with the Oct-1 POUH domain faces the
Oct-1 molecule (Fig. 8). In this representation the orien-
tation of VP16 is the same as the front view shown in
Figures 3A and 7B.
Because the unstructured region of VP16 is also in-
volved in binding DNA (Shaw et al. 1995; Lai and Herr
1997), we imagine that on association with Oct-1 the
unstructured region adopts a stable conformation that
includes contacts with the DNA. The GARAT sequence
of the TAATGARAT element lies between the D ele-
ment VP16-binding site and the TAAT POUH domain-
binding site in the model, and therefore the GARAT se-
quence is an attractive site for interaction with the un-
structured region of VP16. We do not know how the
other member of the VP16-induced complex, HCF, may
bind in the complex. Because the sequences in VP16
bound by HCF lie adjacent to the sequences involved in
interaction with the DNA and the Oct-1 POUH domain,
we imagine that HCF could bind VP16 near the Oct-1
POUH domain and perhaps stabilize the structure of
VP16 that contacts the Oct-1 POUH domain.
The model shown in Figure 8 may explain how the
Oct-1 POUS domain can display flexibility in its inter-
action with DNA in the VP16-induced complex. UV-
Figure 6. The structured region of the conserved VP16 core
is involved in DNA-sequence recognition. (A) Electrophoretic
mobility retardation assay comparing the TAATGARAT-ele-
ment recognition properties of HSV-1 VP16 (H-VP16) lacking
the transcriptional activation domain (residues 1–412), full-
length BHV-1 VP16 (B-VP16), and a recombinant VP16 protein
(B/H-VP16) containing BHV-1 VP16 residues 1–356 and HSV-1
VP16 residues 353–412. All samples contained partially purified
HeLa-cell Oct-1 and HCF (the wheat germ agglutinin fraction;
Wilson et al. 1993). Odd-numbered lanes contained the TAAT-
GARAT DNA probe H-TAATP; even-numbered lanes contained
the TAATGARAT DNA probe B-TAATP described previously
(Huang and Herr 1996). (Lanes 1,2) No VP16; (lanes 3,4) H-VP16;
(lanes 5,6) B/H-VP16; (lanes 7,8) B-VP16. Only the Oct-1-DNA
(Oct-1) and VP16-induced complexes (VIC) are shown. (B) Dia-
grams of the H-VP16, B-VP16, and recombinant B/H-VP16 pro-
teins. The dark (H-VP16) and light (B-VP16) shaded segments
represent the conserved VP16-core sequences from HSV-1 and
BHV-1, respectively.
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induced protein-to-DNA crosslinking has shown that, in
a VP16-induced complex, the Oct-1 POUS domain can
lie to the right of the POUH domain as shown in Figure
8 or on the opposite side of the POUH domain over the
GARAT element (Cleary et al. 1997). As can be seen
from the center of the model in Figure 8, there is space
for the Oct-1 POUS domain to adopt such a configuration
in the major groove of the DNA between the Oct-1
POUH domain and VP16.
Conclusions
We have described the crystallographic structure of the
conserved region of HSV-1 VP16. This region of VP16 is
responsible for formation of the VP16-induced complex
with Oct-1, HCF, and DNA. Although the majority of
the conserved VP16 core is highly structured with many
internal networks of ionic interactions, a carboxy-termi-
nal region that interacts with Oct-1, HCF, and DNA is
disordered in the crystal structure. By analogy to the
yeast MATa2 protein (Li et al. 1995), we suggest that this
region of VP16 becomes structured on VP16-induced
complex formation. The results of a mutagenesis study
(Ace et al. 1988) suggest that one surface of VP16 is in-
volved in virion assembly and the other in VP16-induced
complex formation. Surprisingly, the structured region
of the VP16 core is involved in DNA recognition in
the VP16-induced complex. Examination of the electro-
static surfaces of the VP16 core suggest that a concave
surface—the seat—forms a DNA-binding surface. In
this view, VP16 represents a throne on which the DNA
sits.
Figure 8. Model of VP16 bound to a TAATGARAT element
with the Oct-1 POU domain. The presentation of VP16 is simi-
lar to that shown in Fig. 7B. The nucleotide sequence of the
DNA in the model is shown at the bottom and originates from
the HSV ICP0 gene promoter. In the graphic, the bases are color
coded as follows: A (red), T (blue), G (yellow), and C (purple).
The blue DNA strand represents the top strand; the red strand
represents the bottom strand of the sequence shown below. The
Oct-1 POUS (POU-S) and POUH (POU-H) domain structures and
the Oct-1 DNA-binding site structure are from Klemm et al.
(1994).
Figure 7. Molecular surface representation (Nicholls et al. 1991) of the electrostatic potential of the VP16 core. The surface charge
distribution was computed at neutral pH and displayed at the level of the solvent-accessible surface, assuming a probe radius of 1.4
Å to represent a water molecule, and dielectric constants of 80 and 2 for the solvent and protein, respectively. The surface is colored:
blue for positive (20 kBT), red for negative (−20 kBT), and white for neutral, where kB is the Boltzmann’s constant and T is the
temperature. Charged side chains are labeled. (A) Left-side view. (B) front view; (C) right-side view. A green cross indicates the location
of a phosphate ion.
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Materials and methods
Overexpression and purification of HSV-1 VP16 core
The glutathione S-transferase (GST)–VP16 fusion expression
construct pET11c–GST–VP16DC (containing HSV-1 residues
1–412) was used as a template for oligonucleotide-directed mu-
tagenesis to remove the sequences encoding VP16 residues
1–48. The resulting fusion protein, GST–VP1649–412 was puri-
fied on a glutathione–agarose column (Smith and Johnson 1988),
and the VP1649–412 core moiety bound to the column was
cleaved from the GST moiety by thrombin digestion, resulting
in the final VP1649–412 core protein and three additional amino-
terminal GST fusion related amino acids (Gly–Ser–Arg). The
VP1649–412 core protein was separated from thrombin by
Q–Sepharose column chromatography and further purified by
Mono-S chromatography. Typically, frozen E. coli from 2 liters
of culture were thawed and resuspended in 40 ml of lysis buffer
(50 mM Tris-HCl at pH 8.0, 100 mM NaCl, 10% glycerol, 2 mM
EDTA, 0.1% 2-mercaptoethanol, 2 mM PMSF, and 1 mg/ml of
lysozyme), ruptured by two passages through a French press and
sonication, and centrifuged to yield a crude supernatant.
Nucleic acids were precipitated from the crude extract by the
slow addition of one-half volume of a 10 mg/ml stock solution
of protamine sulfate and removed by centrifugation. The cleared
supernatant was loaded onto a glutathione–agarose column (20
ml bed volume) equilibrated with the lysis buffer. The
flowthrough was collected and loaded onto the column again.
The column was then washed twice with five bed volumes of
buffer A (50 mM Tris-HCl at pH 8.3, 10% glycerol, 2.5 mM
Ca2Cl) with first 300 mM NaCl and then 100 mM NaCl. One-bed
volume of buffer A with 25 Units of thrombin (Calbiochem) was
loaded onto the column and digestion was performed for 1 hr at
room temperature. The protein was eluted from the column by
addition of a second one-bed volume of buffer A with thrombin
and the digestion and collection repeated. Thrombin was re-
moved by chromatography over a 20-ml Q–Sepharose column in
which the VP1649–412 core protein passed through the column.
Remaining contaminants were removed by chromatography
over a Pharmacia Mono-S (10/10) FPLC column. The protein
was eluted in buffer A with a linear NaCl gradient; the
VP1649–412 core protein eluted at ~ 300 mM NaCl.
Crystallization and X-ray data collection
Crystals were observed under the condition of 20% (wt/vol)
polyethylene glycol 8000, 50 mM K phosphate (pH 4.0), of a
sparse matrix screening (Hampton Research; Jancarik and Kim
1991) at 16 °C in a 6 µl hanging drop containing equal volumes
of protein solution (10 mg/ml or higher) and the mother liquor.
Rod-like crystals with an average dimension of 0.2 × 0.2 × 1.0
mm3 were only reproduced by using the microseeding tech-
nique. Crystals were of the orthorhombic space group P212121,
determined based on the systematic absences of reflections
along the three axes. There was one molecule per asymmetric
unit. The crystals diffracted from 3.5–3 Å to 2.1 Å resolutions
(Tables 1 and 2), by X-rays produced by an Elliott GX-21 rotating
anode generator and the synchrotron radiation at the National
Synchrotron Light Source. The diffraction limits varied from
crystal to crystal depending largely on the success of microseed-
ing. The best data collected was 2.1-Å resolution from crystal
number 7, which had slightly smaller cell dimensions in b and
c axes (Table 2). X-ray data sets collected from crystal number 1
to 5 were measured at approximately 16°C by an R-AXIS II
imaging plate detector (l = 1.54 Å). Data sets collected from
crystal number 6 to 8 were measured by a MarResearch imaging
plate detector on beam line X12-C under cryogenic condition.
Crystals were quenched into liquid nitrogen and then main-
tained at 95 K in a stream of liquid nitrogen gas. The resulting
images were processed using the program HKL (Otwinowski
and Minor 1997).
Phasing, model building, and refinement
Two useful heavy atom derivatives, a smaller mercurial com-
pound (HgCl2) and a larger one (p-chloromercuriphenyl sulfo-
nate; pCMBS) were obtained by soaking the crystals in 0.25 mM
HgCl2 for ~ 8 hr and 3.0 mM pCMBS for ~ 1–3 days. The mercury
atom had reacted with the sulfur atom of five (C78, C176, C255,
C257, and C258) out of six cysteines. The positions of the mer-
cury atoms were first determined from difference Patterson syn-
theses and confirmed by difference Fourier methods. The mul-
tiple isomorphous replacement method was used to generate
initial protein phases, using the program package PHASES
(Furey and Swaminathan 1997). The resulting initial map at 3 Å
was of sufficient quality to place several helices, particularly the
long helix aF, in recognizable densities using the molecular
modeling program O (Jones et al. 1991). The position of one of
the mercury atoms immediately identified the side chain of the
conserved C176 in helix aF. The surface loops connecting the
secondary structures, however, were undetectable in the
Wang’s (1985) solvent flatten MIR map.
A pCMBS-soaked crystal (number 6) was then used for data
collected at two distinct wavelengths. These two wavelengths
correspond to the peak (maximum Df88, l = 1.01299 Å) and the
inflection point (minimum Df8, l = 1.015562 Å) of the Hg-con-
taining crystal absorption spectrum. The multiwavelength
anomalous diffraction data at the absorption K-edge of mercury
were treated as if they were from a multiple isomorphous re-
placement experiment (Ramakrishnan and Biou 1997). In our
case, we combined data from a conventional rotating-anode gen-
erator and data from the synchrotron source as well (Xu et al.
1997). With these data we combined up to as many as six dif-
ferent sources of phase information: four isomorphous sets from
crystal number 3 to 5, and two anomalous scattering sets from
l1 and l2 of crystal number 6. By systematically trying various
combinations/modifications of phases, with the indications
from the positions of mercury atoms, we placed amino acids
48–349 and 395–402 of VP16 into the density. Parallel analysis
of selenomethionine VP16 core (49–412) protein was used to
confirm the location of methionines (Hendrikson et al. 1990).
The resultant model was refined against a higher resolution data
set (up to 2.1 Å) collected from crystal number 7 (Table 2) in the
resolution range of 7.0–2.1 Å by simulated annealing and least-
square minimization using the X-PLOR program suite (Bru¨nger
1992). The pdb coordinates code is 16VP.
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